9.76
-0.34(-3.37%)
Currency In USD
| Previous Close | 10.1 |
| Open | 10.08 |
| Day High | 10.13 |
| Day Low | 9.76 |
| 52-Week High | 14.76 |
| 52-Week Low | 7.1 |
| Volume | 1,520 |
| Average Volume | 10,116 |
| Market Cap | 49.18M |
| PE | 5.95 |
| EPS | 1.64 |
| Moving Average 50 Days | 10.86 |
| Moving Average 200 Days | 11.82 |
| Change | -0.34 |
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
GlobeNewswire Inc.
Mar 10, 2026 12:00 PM GMT
Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today annou
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026
GlobeNewswire Inc.
Mar 09, 2026 12:00 PM GMT
Oak Ridge, TN, March 09, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that CEO and President Michael Feldschuh will participate in the iAccess Virtual Alpha Best Ideas
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
GlobeNewswire Inc.
Mar 03, 2026 1:00 PM GMT
Strategic Realignment to Clinical Growth Supported by FDA 510(k) Clearance for Next-Generation Blood Volume Analyzer Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement te